Trials / Unknown

UnknownNCT02862054

Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology

Status: Unknown
Phase: Phase 2 / Phase 3
Study type: Interventional
Enrollment: 30 (estimated)

Sponsor: Beijing Friendship Hospital · Academic / Other
Sex: All
Age: 14 Years – 60 Years
Healthy volunteers: Not accepted

Summary

To evaluate the clinical value of splenectomy as a treatment for relapsed haemophagocytic lymphohistiocytosis (HLH) in patient with unknown etiology.

Conditions

Hemophagocytic Lymphohistiocytosis

Interventions

Type	Name	Description
PROCEDURE	splenectomy

Timeline

Start date: 2015-01-01
Primary completion: 2017-12-01
First posted: 2016-08-10
Last updated: 2016-08-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02862054. Inclusion in this directory is not an endorsement.